A new method of tracheoesophageal fistula treatment: Using an atrial septal defect occluder device for closure—The first Turkish experience

Ersöz, Hasan; Nazlı, Cem

doi:10.1007/s11748-018-0933-y

Cited by 7 publications

(5 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Esophageal atresia, caused by incomplete embryonic compartmentalization of the foregut commonly occurs with a tracheoesophageal fistula [9]. It is thought-provoking to keep in mind that esophageal malformations are the product of abnormalities during embryogenesis where members of the forkhead-box family of transcription factors, as well as the SRY-box transcription factor SOX2, are preferentially expressed in embryonic fibroblast the former and epithelial subpopulations the latter [10,11].…”

Section: Discussionmentioning

confidence: 99%

“…Therefore, at this time the fistula should be named call it a "Refractory tracheoesophageal fistula" (refTEF). A minimally invasive alternative consists of the endoscopic placement of a cardiac septal occluder (CSO) [8,9]. The purpose of this report is to demonstrate that refTEF closure can be achieved by the endoscopic placement of a cardiac septal occluder in a paediatric patient with refractory TEF.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Endoscopic Repair of Refractory Tracheoesophageal Fistula with a Cardiac Septal Occluder Device in a 12 Years-Old Patient

Alfredo,

Antonio,

Jesús

et al. 2024

AJP

View full text Add to dashboard Cite

Purpose: Esophageal atresia (EA) and tracheoesophageal fistula (TEF) are rare anomalies in neonates that must be surgically repaired by esophageal reconstruction with or without ligation of the fistula. Recurrent tracheoesophageal fistula (rTEF) occurs in 3-15% of primary surgical repairs in esophageal atresia; it is associated with recurrent hospital admissions and up to 27% short term mortality. Dependable reparation very often proves difficult by standard surgical techniques. Using oesophageal fully covered self-expandable metal stents in adult patients yields a <50% efficacy and other endoscopic techniques such as occlusion by clips or glue show no better results. A minimally invasive alternative is the use of vascular plug septal occluders. We report the efficacy of endoscopic placement of a cardiac septal occluder (CSO) in a paediatric patient. Clinical case: A 12-year-old female with recurrent (rTEF) and refractory tracheoesophageal fistula (refTEF) was subjected to an refTEF closure procedure via endoscopic placement of a cardiac septal occlusion device. Conclusion: Debate regarding the gold standard of rTEF treatment closure a hot debate but flexible endoscopy is an accepted alternative. This report describes the successful fixing of a refTEF using a cardiac septal occluder. After four weeks follow up, no re-incidence of the tracheoesophageal fistula was detected. The results advocate for the endoscopic closure of refractory tracheoesophageal fistula with cardiac occluders in children thus establishing a promising therapeutical alternative in refTEF in paediatric population patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Endoscopic Repair of Refractory Tracheoesophageal Fistula with a Cardiac Septal Occluder Device in a 12 Years-Old Patient

Alfredo,

Antonio,

Jesús

et al. 2024

AJP

View full text Add to dashboard Cite

show abstract

“…Currently, there are various treatment options for TEF (conservative, interventional, or surgical repair). Interventional modalities of treatment also had been attempted including hybrid insertion of a T-tube, endoscopic esophageal stenting, endoscopic clipping of the fistulous tract, using an atrial septal defect occluder device, and endosponge placement with endoluminal vacuum therapy, and so on ( 3 , 10 , 11 ). However, these interventions are not always applicable due to the character of the TEF or each hospital’s capacity.…”

Section: Discussionmentioning

confidence: 99%

Multidisciplinary team approach on tracheoesophageal fistula in a patient with home ventilator

Kang¹,

Yi²,

Kim³

et al. 2022

J Thorac Dis

View full text Add to dashboard Cite

A 68-year-old man was transferred to our tertiary hospital. Ten years ago, he received radiation therapy for tonsil cancer, and while there was no evidence of recurrence, he suffered from recurrent aspiration. We treated his aspiration pneumonia in the intensive care unit. Prior to his discharge, he received percutaneous dilatational tracheostomy (PDT) before he was transferred to a nursing hospital. Nine months later, he was readmitted owing to tracheoesophageal fistula (TEF). However, he was considered unsuitable for conservative intervention after a multidisciplinary team discussion. Esophageal stent insertion was impossible due to the high level of TEF in the esophagus. Additionally, the size of the TEF could not be covered by an endosponge and endoluminal vacuum therapy, and there was no tracheal stent that could cover his large trachea. The preceding percutaneous enteral gastrostomy (PEG) procedure was required for the primary closure operation of the esophagus; however, family's consent could not be obtained. After 1month, the patient and his family changed their minds and agreed to the procedure and we attempted to perform PEG procedure. However, we could not proceed with PEG owing to stenosis in the inlet of the esophagus.Then, the patient deteriorated clinically and died due to pneumonia with septic shock.

show abstract

“…The use of Amplatzer occluders, initially designed for cardial septal defect occlusion, in the treatment of non-malignant refractory ERF has been reported in 10 case reports (11 patients) since 2006 5 6 10 11 12 13 14 15 16 17 . In four of 11 cases, the ERF occurred after esophagectomy, and in four of 11 patients after prolonged mechanical ventilation.…”

Section: Discussionmentioning

confidence: 99%

Amplatzer occluders for refractory esophago-respiratory fistulas: a case series

et al. 2021

View full text Add to dashboard Cite

Background and study aims Endoscopic management of esophagorespiratory fistulas (ERF) is challenging and currently available options (stents, double pigtail, endoscopic vacuum therapy) are not very effective. We report the feasibility and efficacy of endoscopic placement of Amplatzer cardiovascular occluders for this indication. Patients and methods This was a single-center, prospective study (June 2019 to September 2020) of all patients with non-malignant ERF persistent after conventional management with esophageal and/or tracheal stents. The primary outcome was the technical feasibility of Amplatzer placement. Secondary outcomes were clinical success defined by effective ERF occlusion and resolution of respiratory symptoms allowing oral food intake. Results Endoscopic placement of Amplatzer occluders was feasible in 83 % of patients (5/6), with a 50 % (3/6) clinical success rate at 9 months. The mortality rate was 33 % (2/6). Conclusions An Amplatzer cardiac or vascular occluder is a feasible and safe treatment option for refractory ERF, with a 50 % short-term clinical success.

show abstract

A new method of tracheoesophageal fistula treatment: Using an atrial septal defect occluder device for closure—The first Turkish experience

Cited by 7 publications

References 18 publications

Endoscopic Repair of Refractory Tracheoesophageal Fistula with a Cardiac Septal Occluder Device in a 12 Years-Old Patient

Endoscopic Repair of Refractory Tracheoesophageal Fistula with a Cardiac Septal Occluder Device in a 12 Years-Old Patient

Multidisciplinary team approach on tracheoesophageal fistula in a patient with home ventilator

Amplatzer occluders for refractory esophago-respiratory fistulas: a case series

Contact Info

Product

Resources

About